- 全部删除
 
您的购物车当前为空
Etalocib (LY293111) 是一种具有口服活性的白三烯(LTB4)受体的拮抗剂,抑制 [3H]LTB4结合的 Ki 值为 25 nM。它还可诱导凋亡。它抑制 LTB4诱导的钙动员,lC50值为 20 nM。

Etalocib (LY293111) 是一种具有口服活性的白三烯(LTB4)受体的拮抗剂,抑制 [3H]LTB4结合的 Ki 值为 25 nM。它还可诱导凋亡。它抑制 LTB4诱导的钙动员,lC50值为 20 nM。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 738  | In stock | |
| 5 mg | ¥ 1,630  | In stock | |
| 10 mg | ¥ 2,380  | In stock | |
| 25 mg | ¥ 4,420  | In stock | |
| 50 mg | ¥ 5,920  | In stock | |
| 100 mg | ¥ 7,980  | In stock | |
| 200 mg | ¥ 10,700  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,030  | In stock | 
Etalocib 相关产品
| 产品描述 | Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.  | 
| 别名 | VML295, LY293111 | 
| 分子量 | 544.6 | 
| 分子式 | C33H33FO6 | 
| CAS No. | 161172-51-6 | 
| Smiles | CCCc1c(OCCCOc2cc(O)c(cc2CC)-c2ccc(F)cc2)cccc1Oc1ccccc1C(O)=O | 
| 密度 | 1.215g/cm3 | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (183.62 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容